Evaluation of the social and economic burden of road traffic noise-attributed myocardial infarction in Bulgarian urban population

Arhiv za Higijenu Rada i Toksikologiju

Volumn 66, Issue 1, 2015, Pages 15-21

  Dzhambov, Angel M ^a   Dimitrova, Donka D ^b  

^a MEDICAL UNIVERSITY OF PLOVDIV   (Bulgaria)

^b MEDICAL UNIVERSITY OF PLOVDIV   (Bulgaria)

Author keywords

Burden of disease; Health economics; Ischemic heart disease; Noise pollution; Quality adjusted life years

Indexed keywords

ADULT; AGED; ARTICLE; BULGARIA; ECONOMIC ASPECT; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; NOISE POLLUTION; QUALITY OF LIFE; RISK FACTOR; SOCIAL ASPECT; TRAFFIC NOISE; URBAN POPULATION; ADVERSE EFFECTS; COMPARATIVE STUDY; COST OF ILLNESS; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL HEALTH; MYOCARDIAL INFARCTION; NOISE; STATISTICS AND NUMERICAL DATA;

BULGARIA; COST OF ILLNESS; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL HEALTH; HUMANS; MYOCARDIAL INFARCTION; NOISE; RISK FACTORS; URBAN POPULATION;

EID: 84929096009     PISSN: 00041254     EISSN: None     Source Type: Journal    
DOI: 10.1515/aiht-2015-66-2562     Document Type: Article

References (36)

1. Ganova-Iolovska M, Kalinov K, Geraedts M. Quality of care of patients with acute myocardial infarction in Bulgaria: a cross-sectional study. BMC Health Serv Res 2009;9:15. doi: 10.1186/1472-6963-9-15.
2. Ministry of Health-National Centre of Public Health and Analyses. Hospitalized Patients (discharged and dec eased) in Hospitals of ICD-10 [displayed 22 July 2014]. Available at http://www.webcitation.org/6RGLCGLuy
3. Ministry of Health-National Statistical Institute. 2013 [Healthcare 2013, in Bulgarian] [displayed 22 July 2014]. Available at http://www. webcitation.org/6RVn1cCWV
4. Marginean I, Precupetu I, Tzanov V, Preoteasa AM, Voicu B. First European Quality of Life Survey: Quality of life in Bulgaria and Roman ia. Luxembourg: Office for Official Publications of the European Communities; 2006 [displayed 22 July 2014]. Available at http://www.eurofound.europa. eu/pubdocs/2006/67/en/1/ef0667en.pdf
5. Dimova A, Rohova M, Moutafova E, Atanasova E, Koeva S, Panteli D, van Ginneken E. Bulgaria health system review. Health Syst Transit 2012;14:1-186. PMID: 22894828
6. Andreeva VA, Sakuma KL. Adapti ng smoking cessation programming to the Bulgarian context. Eval Health Prof 2008;31:290-6. doi: 10.1177/0163278708320149
7. Stefanov TS, Temelkova-Kurktschiev TS. The metabolic syndrome in Bulgaria. Folia Med (Plovdiv) 2011;53:5-14. doi: 10.2478/v10153-011-0061-2
8. Anand SS, Islam S, Rosengren A, Franzosi MG, Steyn K, Yusufali AH, Keltai M, Diaz R, Rangarajan S, Yusuf S; INTERHEART Investigators. Risk factors for myocardial infarction in women and men: i nsights from the INTERHEART study. Eur Heart J 2008;29:932-40. doi: 10.1093/eurheartj/ehn018
9. Babisch W. Updated exposure-response relationship between road traffic noise and coronary heart diseases: A metaanalysis. Noise Health 2014;16:1-9. doi: 10.4103/1463-1741.127847.
10. Goines L, Hagler L. Noise pollution: a modem plague. South Med J 2007;100:287-94. PMID: 17396733
11. Andersson K, Lindvall T. Health Effects of Community Noise; Evaluation of the Nordic Project on " The Health Effects of Community Noise" . Copenhagen: Nordic Council of Ministers; 1988.
12. Spreng M. Central nervous system activation by noise. Noise Health 2000;2:49-58. PMID: 12689471
13. Ising H, Kruppa B. Health effects caused by noise: evidence in the literature from the past 25 years. Noise Health 2004;6:5-13. PMID: 15070524
14. Westman JC, Walters JR. Noise and stress: a comprehensive approach. Environ Health Perspect 1981;41:291-309. PMID: 7333243
15. WHO Regional Office for Europe. Burden of Disease from Environmental Noise. Quantification of Healthy Life Years Lost in Europe. Copenhagen: WHO Regional Office for Europe 2011.
16. Noise Observation and Information Service for Europe (NOISE). Copenhagen, European Environment Agency [displayed 22 July 2014G. Available at http://noise.eionet. europa.eu/
17. Berglund B, Lindv all T, Schwella DH, editors. Guidelines for Community Noise. Geneva: World Health Organization; 1999 [displayed 22 July 2014]. Available at http://www.who. int/docstore/peh/noise/noiseindex.html
18. Ricar do-AEA. Update of the Handbook on External Costs of Transport-Report for the European Commission: DG MOVE; 2014 [displayed 22 July 2014]. Available at http://ec.europa.eu/transport/themes/sustainable/studies/doc/2014-handbook-external-co sts-transport.pdf
19. Harding AH, Frost GA, Tan E, Tsuchiya A, Mason HM. The cost of hypertension-related ill-health attributable to environmental noise. Noise Health 2013;15:437-45. doi : 10.4103/1463-1741.121253
20. Paunovic K, Belojevi G. Burden of myocardial infarction attributable to road-traffic noise: A pilot study in Belgrade. Noise Health 2014;16:374-9. doi: 10.4103/1463-1741.144415
21. Laaksonen M. Population Attributable Fraction (PAF) in Epidemiologic Follow-up Studies [PhD thesis]. Helsinki: National Institute for Health and Welfare, Finland; 2010 [displayed 22 July 2014]. Available at http://www. webcitation.org/6RGXvijCr
22. Kirkdale R, Krell J, O 'Hanlon Brown C, Tuthill M, Waxman J. The cost of a QALY. QJM 2010;103:715-20. doi: 10.1093/qjmed/hcq081
23. Mathers CD, Bernard C, Iburg KM, Inoue M, Fat DM, Shibuya K, Stein C, Tomijima N, Xu H. Global Burden of Disease in 2002: Data sources, methods and results. World Health Organisation; 2003 (Revised February 2004) [displayed 22 July 2014]. Available at http://www.who.int/healthinfo/paper54.pdf
24. van Domburg RT, Sonnenschein K, Nieuwlaat R, Kamp O, Storm CJ, Bax JJ, Simoons ML. Sus tained benefit 20 years after reperfusion therapy in acute myocardial infarction. J Am Coll Cardiol 2005;46:15-20. doi: 10.1016/j. jacc.2005.03.047
25. Annemans L, Lamotte M, Clarys P, Van den Abeele E. Health economic evaluation of controlled and maintained physical exercise in the prevention of cardiovascular and other prosperity diseases. Eur J Cardiovasc Prev Rehabil 2007;14:815-24. doi: 10.1097/HJR.0 b013e3282ef514f
26. Riegelman R. Non-communicable diseases. In: Public Health 101: Healthy People-Healthy Populations. London: Jones and Bartlett Publishers; 2010. p. 94.
27. European Commiss ion, EUROSTAT. GDP and beyond, Measuring quality of life in the EU; 2014 [displayed 22 July 2014]. Available at http://epp.eurostat.ec.europa.eu/cache/ITY-PUBLIC/3-19032014-CP/EN/3-19032014-CP-EN. PDF
28. Eu ropean Commission, EUROSTAT. Annual national accounts (nama) [displayed 22 July 2014]. Available at http://epp.eurostat.ec.europa.eu/cache/ITY-SDDS/EN/nama-esms.htm
29. Ministry of Health. [National Invasive Cardiology Registry, in Bulgarian]. [displayed 22 July 2014]. Available at http://www.mh.government.bg/
30. den Boer LC, Schroten A. Traffic noise reduction in Europe. Report. CE Delft; 2007 [displayed 22 July 2014]. Available at http://www.transportenvironment.org/sites/te/files/media/2008-02-traffic-noise-ce-delft-report.pdf
31. Poirazis H. Double Skin Faç ades: A Literature Review. A report of IEA SHC Task 34 ECBCS Annex 43; 2006 [displayed 22 July 2014]. Available at http://www.ecbcs.org/docs/Annex-43-Task34-Double-Skin-Facades-A-Literature-Review.pdf
32. Dzhambov AM, Dimitrova DD. Urban green spaces' effectiveness as a psychological buf fer for the negative health impact of noise pollution: A systematic review. Noise Health 2014;16:157-65. doi: 10.4103/1463-1741.134916.
33. World Health Organization (WHO). Evaluation and Use of Epidemiolo gical Evidence for Environmental Health Risk Assessment. Guideline document. Copenhagen: WHO Regional Office for Europe, 2000 [displayed 20 June 2014]. Available at http://www.euro.who.int/document/e68940.pdf
34. De Sme dt D, Kotseva K, De Bacquer D, Wood D, De Backer G, Dallongeville J, Seppo L, Pajak A, Reiner Z, Vanuzzo D, Georgiev B, Gotcheva N, Annemans L. Cost-effectiveness of optimizing prevention in patients wi th coronary heart disease: the EUROASPIRE III health economics project. Eur Heart J 2012;33:2865-72. doi: 10.1093/eurheartj/ehs210
35. Petrova G, Ivanova A, Czech M, Valov V, Wrona W, Niewada M, Savova A. Liraglutide vs. Exenatide in Combination with Metformin and/or Sulfonylurea Therapy in Type 2 Diabetes Mellitus Therapy in Bulgaria. A Mo delling Study. Comptes rendus de l'Acade'mie bulgare des Sciences 2011;64:1507-14.
36. Sassi F. Calculating QALYs comparing QALY and DALY calculations Health Policy Plan 2006, 21, 402-8., 10.1093/heapol/czl018